Hormonal health

OTC Progesterone Cream: What Evidence Supports

Save

Over-the-counter progesterone creams have thin evidence, because most deliver low, variable blood levels and are not proven to protect the uterine lining. Wild yam creams do nothing on their own, since the body cannot turn wild yam into progesterone. Menopause guidance points to FDA-approved, prescription options instead of compounded creams.

Last updated: July 2026

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

What are OTC progesterone creams?

Drugstore progesterone creams come in two very different types, and the label rarely makes the difference clear. Some contain actual progesterone, often labeled USP progesterone; others contain only wild yam extract or other plant compounds.

Wild yam creams are a common source of confusion, because the diosgenin they contain can be turned into progesterone in a factory but not inside the human body. Products are sold as tubs and pumps promising better sleep, calmer moods, and relief for perimenopause symptoms. Only a handful of small trials, most lasting under 12 weeks, have tested these creams, so the marketing outpaces the data by a wide margin.

Does progesterone actually absorb through the skin?

Progesterone can cross the skin, but the amount that reaches the bloodstream from most creams is low and unpredictable. Small studies of transdermal progesterone show blood levels that stay a fraction of what oral or vaginal prescriptions achieve, and readings can change substantially within 24 hours.

That matters most for one job: when a woman takes estrogen and still has a uterus, a progestogen is needed to protect the lining from overgrowth. According to the North American Menopause Society, compounded and over-the-counter progesterone are not recommended for that protection, because they are not proven to prevent endometrial hyperplasia 1. Saliva levels can even rise while the tissue stays unprotected.

What symptoms do people use it for, and does it help?

Creams are marketed for menopausal symptoms, PMS, sleep, and vaguely defined estrogen dominance, and the evidence is mixed to weak. For premenstrual symptoms, a Cochrane review found the treatments with the clearest evidence are SSRIs, not progesterone 3; a comparative effectiveness review of menopause therapies likewise found insufficient evidence for compounded and non-prescription hormones 6.

Estrogen dominance is not a recognized medical diagnosis, and no lab confirms it. Across the luteal phase, pregnancy, the postpartum weeks, and the perimenopausal transition, progesterone naturally rises and falls, so feeling different on a cream can reflect timing as much as the product; menopause itself usually arrives between ages 45 and 55, according to the World Health Organization 4. Placebo responses in these trials are large, often 30 to 50 percent.

What are the safer, studied alternatives?

Women who want progesterone have prescription, FDA-approved options that are actually studied, including micronized progesterone by mouth, which has more than 20 years of safety data, and progestogen-containing HRT regimens 2. When estrogen is used for menopause symptoms and the uterus is intact, guidelines pair it with an adequate progestogen specifically to protect the lining 5.

These regimens have known dosing, quality control, and safety data that a tub of cream does not. Options like relief for hot flashes at night are better studied than any cream, and our guide to hormone therapy safety in menopause lays out the current consensus. Prescription care also means a clinician tracks the one risk a cream can hide: an unprotected uterine lining.

When OTC progesterone questions need a clinician

A clinician can turn wanting to try progesterone into a plan that is safe and actually likely to help. A primary care clinician or gynecologist can pinpoint whether your symptoms point to perimenopause, a thyroid issue, PMS, or something else, and match you to a treatment with real evidence.

That review also catches the situation an OTC cream can quietly worsen: using estrogen without enough progestogen to protect the uterus. If you are weighing a cream against irregular periods in your 40s, a short visit can save months of guessing. Gale can help you prepare questions before you go.

Common questions

The evidence is thin. Most creams deliver low, variable blood levels, and they are not proven to protect the uterine lining or to reliably relieve symptoms. Wild yam creams do even less, because the body cannot convert wild yam into progesterone.

That combination is the main safety concern. If you take estrogen and still have a uterus, you need a progestogen proven to protect the lining, and OTC creams are not recommended for that purpose. This is a situation to review with a clinician rather than self-manage.

Estrogen dominance is a wellness term, not a recognized medical diagnosis, and no lab test confirms it. Because it is not a defined condition, there is no evidence that a progesterone cream corrects it.

FDA-approved, prescription options such as oral micronized progesterone and progestogen-containing hormone therapy regimens have known dosing and safety data. A clinician can help decide whether any of them fits your symptoms and history.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

When to get progesterone questions answered properly

  • —Using estrogen, including a cream or pellet, without a proven progestogen when you still have a uterus is a reason to seek clinician review, because the uterine lining may be unprotected.
  • —Any new, heavy, or postmenopausal vaginal bleeding is a reason to seek prompt clinician evaluation.
  • —Symptoms you are treating with a cream that are not improving, or are worsening, are a reason to have a clinician reassess the cause.
  • —A personal or family history of breast cancer, blood clots, or stroke is a reason to discuss any hormone product with a clinician before use.

This article is general health education, not a prescription or medical advice; whether any hormone is appropriate is a decision for a primary care clinician or gynecologist who knows your history.

References

  1. 1.Faubion SS, Crandall CJ, Davis L, et al. (The North American Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Compounded and over-the-counter (non-prescription) progesterone is not recommended, in part because it is not proven to protect the endometrium; FDA-approved options are preferred.
  2. 2.MedlinePlus, U.S. National Library of Medicine (NIH) (2026). Hormone Replacement Therapy. MedlinePlus, U.S. National Library of Medicine (NIH). link ✓When estrogen is used with an intact uterus, a progestogen is needed to protect the uterine lining; FDA-approved progesterone and combined regimens are the standard forms.
  3. 3.Marjoribanks J, Brown J, O'Brien PMS, Wyatt K (2013). Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001396.pub3 ✓For premenstrual syndrome, SSRIs are the treatment with the clearest evidence of benefit, in contrast to progesterone creams marketed for PMS.
  4. 4.World Health Organization (WHO) (2024). Menopause (fact sheet). World Health Organization (WHO). link ✓Menopause usually occurs between ages 45 and 55, and the perimenopausal transition involves natural hormone fluctuation over several years.
  5. 5.National Institute for Health and Care Excellence (NICE) (2026). Menopause: identification and management (NG23). National Institute for Health and Care Excellence (NICE). link ✓Menopausal hormone therapy that includes systemic estrogen for a woman with a uterus is combined with an adequate progestogen to protect the endometrium.
  6. 6.Agency for Healthcare Research and Quality (AHRQ) (2015). Menopausal Symptoms: Comparative Effectiveness of Therapies. Agency for Healthcare Research and Quality (AHRQ). link ✓Comparative effectiveness review of menopause therapies finds insufficient evidence to support compounded and non-prescription hormone preparations.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library